Virginia Commonwealth University: Parkinson Disease trials
The registry lists 12 Parkinson Disease studies with Virginia Commonwealth University as lead sponsor. 0 are open to participants now and 6 have results posted.
Phase 1 1Phase 2 1No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Istradefylline for Parkinson Disease With Cognitive ImpairmentCompletedNCT05333549Phase 2Results posted
- SCH: Context-aware Freezing of Gait Mitigation in Real-world SettingCompletedNCT04746846Results posted
- Safety and Efficacy of State-of-the-Art Exoskeleton Technology to Improve Mobility in Parkinson's DiseaseTerminatedNCT04587193Not applicableResults posted
- Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's DiseaseCompletedNCT03883217Not applicableResults posted
- Vibration Impact on Parkinson's TremorCompletedNCT03799614Not applicableResults posted
- Erythromycin in Parkinson's DiseaseCompletedNCT02005029Not applicableResults posted
- Vibrational Therapy to Improve Gait and Balance in Parkinson's DiseaseWithdrawnNCT03872115Not applicable
- Self-Managed Intervention for Anxiety in Parkinson's DiseaseCompletedNCT03859180Not applicable
- RQ-00000010 for Gastroparesis and Constipation in Parkinson's DiseaseCompletedNCT02838797Phase 1
- Computer-based Cognitive Training for Individuals With Parkinson's DiseaseCompletedNCT02225314Not applicable
- Expressive Writing for Individuals With Parkinson's Disease and Their CaregiversCompletedNCT02217735Not applicable
- A Trial of Neurocognitive and Supportive Therapy Interventions for Individuals With Parkinson's DiseaseCompletedNCT01646333Not applicable